Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...

Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...

How do we translate individual experiences into support that helps others and create support that feels personal but remains ...

Camena Bioscience, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...